$26.2B
$-614M
(-2.3%)

IN
· Age 70
Source of wealth: Pharmaceuticals
Industry: healthcare
Residence: Mumbai, IN
{
"bio": [
"The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs.",
"The company is India's most valuable listed pharma outfit and gets two-thirds of its $5.3 billion annual revenue from overseas markets.",
"He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion.",
"In 2023, Sun Pharma completed the $576 million acquisition of U.S.-based Concert Pharmaceuticals."
],
"about": [
"Photos of Shanghvi's family deity, Shrinathji, adorn Sun's factories and offices.",
"Shanghvi 's favorite cuisine is south Indian."
]
}